نتایج جستجو برای: mdr model

تعداد نتایج: 2111644  

2014
Xu Wang Jonathan J. Beitler Hong Wang Michael J. Lee Wen Huang Lydia Koenig Sreenivas Nannapaneni A. R. M. Ruhul Amin Michael Bonner Hyung Ju C. Shin Zhuo Georgia Chen Jack L. Arbiser Dong M. Shin

Resistance to chemotherapy remains a major obstacle in cancer therapy. This study aimed to evaluate the molecular mechanism and efficacy of honokiol in inducing apoptosis and enhancing paclitaxel chemotherapy in pre-clinical multi-drug resistant (MDR) cancer models, including lineage-derived human MDR (KB-8-5, KB-C1, KB-V1) and their parental drug sensitive KB-3-1 cancer cell lines. In vitro an...

Journal: :Journal of clinical microbiology 2011
Adriana Cadilla Michael Z David Robert S Daum Susan Boyle-Vavra

Mupirocin is a topical antimicrobial used to eradicate methicillin-resistant Staphylococcus aureus (MRSA) colonization, usually in the absence of susceptibility testing. We hypothesized that high-level (HL) mupirocin resistance was associated with multidrug resistance (MDR). To this end, unique patient isolates identified at our institution during 2008 were stratified into those resistant to ≥ ...

Journal: :Biophysical journal 2003
Fatima H Labeed Helen M Coley Hilary Thomas Michael P Hughes

In cancer, multidrug resistance (MDR) is the simultaneous resistance of tumor cells to different natural product anticancer drugs that have no common structure. This is an impediment to the successful treatment of many human cancers. A common correlate of MDR is the overexpression of a membrane protein, P-glycoprotein. Many studies have shown that MDR can be reversed after the use of substrate ...

2013
Vivian M. Rumjanek Raphael S. Vidal Raquel C. Maia

The hallmark of CML (chronic myeloid leukaemia) is the BCR (breakpoint cluster region)-ABL fusion gene. CML evolves through three phases, based on both clinical and pathological features: a chronic phase, an accelerated phase and blast crisis. TKI (tyrosine kinase inhibitors) are the treatment modality for patients with chronic phase CML. The therapeutic potential of the TKI imatinib is affecte...

2010
Casey S. Greene Nicholas A. Sinnott-Armstrong Daniel S. Himmelstein Paul J. Park Jason H. Moore Brent T. Harris

MOTIVATION Epistasis, the presence of gene-gene interactions, has been hypothesized to be at the root of many common human diseases, but current genome-wide association studies largely ignore its role. Multifactor dimensionality reduction (MDR) is a powerful model-free method for detecting epistatic relationships between genes, but computational costs have made its application to genome-wide da...

Journal: :The Journal of infectious diseases 2011
Shashikant Srivastava Jotam G Pasipanodya Claudia Meek Richard Leff Tawanda Gumbo

BACKGROUND It is believed that nonadherence is the proximate cause of multidrug-resistant tuberculosis (MDR-tuberculosis) emergence. The level of nonadherence associated with emergence of MDR-tuberculosis is unknown. Performance of a randomized controlled trial in which some patients are randomized to nonadherence would be unethical; therefore, other study designs should be utilized. METHODS ...

2013
Chang Chen Chuanhong Wu Xinhua Lu Zhiyong Yan Jian Gao Hui Zhao Shaojing Li

Glutathione S-transferase (GST) is the key enzyme in multidrug resistance (MDR) of tumour. Inhibition of the expression or activity of GST has emerged as a promising therapeutic strategy for the reversal of MDR. Coniferyl ferulate (CF), isolated from the root of Angelica sinensis (Oliv.) Diels (Radix Angelicae sinensis, RAS), showed strong inhibition of human placental GST. Its 50% inhibition c...

2011
Timothy F. Brewer Howard W. Choi Carlos Seas Fiorella Krapp Carlos Zamudio Lena Shah Antonio Ciampi S. Jody Heymann Eduardo Gotuzzo

BACKGROUND Multiple drug-resistance in new tuberculosis (TB) cases accounts for the majority of all multiple drug-resistant TB (MDR-TB) worldwide. Effective control requires determining which new TB patients should be tested for MDR disease, yet the effectiveness of global screening recommendations of high-risk groups is unknown. METHODS Sixty MDR-TB cases with no history of previous TB treat...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005
Aurora E Pop-Vicas Erika M C D'Agata

BACKGROUND The prevalence of multidrug resistance (MDR) among gram-negative bacilli is rapidly increasing. Quantification of the prevalence and the common antimicrobial coresistance patterns of MDR gram-negative bacilli (MDR-GNB) isolates recovered from patients at hospital admission, as well as identification of patients with a high risk of harboring MDR-GNB, would have important implications ...

Journal: :Critical Care 2008
Pieter O Depuydt Dominique M Vandijck Maarten A Bekaert Johan M Decruyenaere Stijn I Blot Dirk P Vogelaers Dominique D Benoit

INTRODUCTION The idea that multidrug resistance (MDR) to antibiotics in pathogens causing ventilator-associated pneumonia (VAP) is an independent risk factor for adverse outcome is still debated. We aimed to identify the determinants of MDR versus non-MDR microbial aetiology in VAP and assessed whether MDR versus non-MDR VAP was independently associated with increased 30-day mortality. METHOD...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید